EquityZen Growth Technology Fund LLC - Series 87
Raised
$298K
Investors
14
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 87 is a Delaware-based pooled investment vehicle filed by EquityZen Inc. on 2017-04-03, raising $298K from 14 investors under Rule 506(b) and Section 3(c)(1) exemptions. This is part of EquityZen's platform of pre-IPO secondary market access vehicles, with over 1,891 related EDGAR entities spanning multiple series and vintage years.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption pattern typical of platforms providing accredited investor access to private company shares. The $21K average investment per investor reflects EquityZen's retail-accessible approach to pre-IPO secondaries, contrasting with institutional-minimum offerings in this category.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Inc.
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Mateo Johnson
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
